Passive

iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.

$21.31

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Neuroscience and Healthcare ETF IBRN
Fund Size
$5.3 Million
Dividend
0.0%
Fees
-
Total Stock Market Index Fund VTI
Fund Size
$1.78 Trillion
Dividend
1.3%
Fees
0.03%
500 Index Fund VOO
Fund Size
$1.35 Trillion
Dividend
1.3%
Fees
0.03%
Core S&P 500 ETF IVV
Fund Size
$590 Billion
Dividend
1.4%
Fees
0.03%
Total International Stock Index Fund VXUS
Fund Size
$447 Billion
Dividend
3.0%
Fees
0.07%
View 1303 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $6.25 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.0 %
Beta Indicates the relationship between the price performance of a share and the market. 0.9817
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 25.83
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -45.88
Profitable Companies 37
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 102.79
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 6.78
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 4.0
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT -18.68
Enterprise Value to Revenue Enterprise value divided by revenue 120.38
Total Debt to Enterprise Value Total debt divided by enterprise value 0.15
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.1016
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -1231.08%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. -328.80%
Return on Assets Indicates a company's profitability in relation to its total assets. -17.94%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -23.96%

Industries

Healthcare 67.9%
Other 9.4%
N/A 22.6%

Market cap

Micro Cap 8%
Small Cap 32%
Mid Cap 36%
Large Cap 24%
Mega Cap 0%

53 Investments

P/E-Ratio
Total Investment
Weight
BlackRock Funds III logo

BlackRock Funds III

P/E-Ratio
n/a
Total Investment
$699 Thousand
Weight
18.0%
Intra-Cellular Therapies Inc logo

ITCI - Manufacturing

Intra-Cellular Therapies Inc

P/E-Ratio
-182.1
Total Investment
$240 Thousand
Weight
6.2%
Neurocrine Biosciences Inc logo

NBIX - Manufacturing

Neurocrine Biosciences Inc

P/E-Ratio
37.7
Total Investment
$189 Thousand
Weight
4.9%
ACADIA Pharmaceuticals Inc logo

ACAD - Manufacturing

ACADIA Pharmaceuticals Inc

P/E-Ratio
12.8
Total Investment
$173 Thousand
Weight
4.4%
Argenx SE logo

ARGX - Manufacturing

Argenx SE

P/E-Ratio
49.2
Total Investment
$168 Thousand
Weight
4.3%
SK Biopharmaceuticals Co Ltd logo

SK Biopharmaceuticals Co Ltd

P/E-Ratio
n/a
Total Investment
$166 Thousand
Weight
4.3%
Supernus Pharmaceuticals Inc logo

SUPN - Manufacturing

Supernus Pharmaceuticals Inc

P/E-Ratio
23.8
Total Investment
$165 Thousand
Weight
4.2%
Catalyst Pharmaceuticals Inc logo

CPRX - Manufacturing

Catalyst Pharmaceuticals Inc

P/E-Ratio
17.1
Total Investment
$164 Thousand
Weight
4.2%
Alkermes PLC logo

Alkermes PLC

P/E-Ratio
n/a
Total Investment
$160 Thousand
Weight
4.1%
PTC Therapeutics Inc logo

PTCT - Manufacturing

PTC Therapeutics Inc

P/E-Ratio
-9.4
Total Investment
$153 Thousand
Weight
3.9%
Integra LifeSciences Holdings Corp logo

IART - Manufacturing

Integra LifeSciences Holdings Corp

P/E-Ratio
-32.3
Total Investment
$151 Thousand
Weight
3.9%
Xenon Pharmaceuticals Inc logo

XENE - Manufacturing

Xenon Pharmaceuticals Inc

P/E-Ratio
-11.7
Total Investment
$150 Thousand
Weight
3.8%
Scholar Rock Holding Corp logo

SRRK - Professional, Scientific, and Technical Services

Scholar Rock Holding Corp

P/E-Ratio
-11.7
Total Investment
$148 Thousand
Weight
3.8%
Biogen Inc logo

BIIB - Manufacturing

Biogen Inc

P/E-Ratio
11.7
Total Investment
$146 Thousand
Weight
3.7%
H Lundbeck A/S logo

H Lundbeck A/S

P/E-Ratio
n/a
Total Investment
$144 Thousand
Weight
3.7%
Sarepta Therapeutics Inc logo

SRPT - Manufacturing

Sarepta Therapeutics Inc

P/E-Ratio
14.8
Total Investment
$142 Thousand
Weight
3.6%
Edgewise Therapeutics Inc logo

EWTX - Manufacturing

Edgewise Therapeutics Inc

P/E-Ratio
-10.1
Total Investment
$138 Thousand
Weight
3.5%
Biohaven Ltd logo

BHVN - Manufacturing

Biohaven Ltd

P/E-Ratio
-2.4
Total Investment
$137 Thousand
Weight
3.5%
Praxis Precision Medicines Inc logo

PRAX - Manufacturing

Praxis Precision Medicines Inc

P/E-Ratio
-3.8
Total Investment
$115 Thousand
Weight
3.0%
Neuren Pharmaceuticals Ltd logo

Neuren Pharmaceuticals Ltd

P/E-Ratio
n/a
Total Investment
$87.3 Thousand
Weight
2.2%
Dyne Therapeutics Inc logo

DYN - Manufacturing

Dyne Therapeutics Inc

P/E-Ratio
-11.7
Total Investment
$77.1 Thousand
Weight
2.0%
BioArctic AB logo

BioArctic AB

P/E-Ratio
n/a
Total Investment
$67.8 Thousand
Weight
1.7%
Anavex Life Sciences Corp logo

AVXL - Manufacturing

Anavex Life Sciences Corp

P/E-Ratio
-15.0
Total Investment
$66.6 Thousand
Weight
1.7%
Axogen Inc logo

AXGN - Manufacturing

Axogen Inc

P/E-Ratio
-51.2
Total Investment
$66.1 Thousand
Weight
1.7%
Avadel Pharmaceuticals PLC logo

AVDL - Manufacturing

Avadel Pharmaceuticals PLC

P/E-Ratio
-18.5
Total Investment
$61 Thousand
Weight
1.6%